Coty To Unveil Strategy to Double Skincare Sales by FY25

Coty Inc. is betting big on skin care. The beauty giant will share details on its planned strategy today during an investor event at its Monaco skincare R&D and manufacturing facility.

Monaco is Coty’s manufacturing center of excellence for its flagship Lancaster skincare brand.

“Coty’s skincare portfolio is one of the most exciting growth areas in our business, with revenues on track to double to $500M-600M by FY25. Our strategy is underpinned by world-recognized brands serving key white space opportunities and consumer needs, 75-years of scientific innovation and leadership, superior patents and distinct intellectual property, and a large and growing team of skincare experts across the organization,” said Sue Y. Nabi, CEO,

According to Nabi, Coty has started it “skincare revolution in Hainan and mainland China, where we are already seeing proof that our brands, formulations, and communication can win over consumers. At the same time, our research & development efforts are focused on the fastest growing consumer needs and health trends. All of this gives us confidence that we can capture significant opportunities in the $150 billion global skincare market.”

Dr. Shimei Fan, Coty’s chief scientific officer, and Constantin Sklavenitis, chief prestige brands officer are scheduled to speak today along with Nabi and CFO Laurent Mercier.

“The combination of Coty's deep skincare heritage and continuing development of innovative IP anchored in the fastest growing consumer health trends, has crafted a unique position for Coty in the beauty market. Through ground-breaking scientific advances, Coty is helping protect consumers from skin disorders, afflictions resulting from pollution and our changing climate, and aging,” said Dr. Fan.

Happi will provide coverage on the event online and its social channels. Check back for updates.